Predictive Parameters for Difficult Tracheal Intubation Identification in Thyroid Surgery

September 19, 2018 updated by: Alessandro De Cassai, University of Padova

Predictive Parameters for Difficult Tracheal Intubation Identification in Thyroid Surgery, a Observational Monocentric Prospective Study

Intubation manoeuvres in patients undergoing thyroid surgery might be challenging for anesthesiologist. Thyroid gland enlargement (goiter) or tissue fibrosis (neoplasms) could alter the physiologic anatomy of upper airways and trachea, resulting in compression or dislocation. We want to evaluate the incidence and identify predictive parameters of difficult intubation in patients undergoing thyroid surgery.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Intubation manoeuvres in patients undergoing thyroid surgery might be challenging for anesthesiologist. Thyroid gland enlargement (goiter) or tissue fibrosis (neoplasms) could alter the physiologic anatomy of upper airways and trachea, resulting in compression or dislocation.

There are few scientific data about airway management and thyroid pathology and the incidence of difficult tracheal intubation in this specific kind of patient is largely variable from 0% to 12.9%. These data have been collected from little statistical samples (from 50 to 326 patients), the results aren't always unanimous and a study evaluating simultaneously all the risk factors for difficult intubation does not exist.

We want to evaluate the incidence and identify predictive parameters of difficult intubation in patients undergoing thyroid surgery.

During pre-anesthetic assessment the following data will be collected:

Inter-incisor gap (cm) Mallampati test (1;2;3;4) Thyromental distance (cm) Prognathism (yes; no) Neck motility (<80°;80-90°;>90°) Total body weight (kg) History of difficult tracheal intubation (yes; no) Tracheal deviation at chest X-Ray (yes; no) Neck circumference (cm) Mediastinal goiter (yes; no) Histologic features (benign; carcinoma)

During the post-anesthesia it will be noted down the following:

Cormack scale (1; 2a; 2b; 3; 4) Number of necessary attempts to intubate (1;2;3;…) Time from induction to intubation (min) Necessity to use advanced airway management devices (Frova; Glidescope; Ambu-scope; fiber-optic; other)

Study Type

Observational

Enrollment (Actual)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Padova, Italy, 35127
        • University of Padova

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients undergoing thyroid surgery

Description

Inclusion Criteria:

  • thyroid surgery

Exclusion Criteria:

  • <18 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Thyroid surgery
Patient undergoing thyroid surgery
Patient undergoing thyroid surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difficult intubation incidence
Time Frame: through study completion, an average of 2 year
Difficult intubation described as Cormack 3 or 4
through study completion, an average of 2 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Histologic features (benign; carcinoma) as predictive parameter for difficult intubation
Time Frame: through study completion, an average of 2 year
preoperative Histologic features (benign; carcinoma) as predictive parameter for difficult intubation
through study completion, an average of 2 year
Neck circumference (cm) as predictive parameter for difficult intubation
Time Frame: through study completion, an average of 2 year
preoperative Neck circumference (cm) as predictive parameter for difficult intubation
through study completion, an average of 2 year
Tracheal deviation at chest X-Ray (yes; no) as predictive parameter for difficult intubation
Time Frame: through study completion, an average of 2 year
preoperative Tracheal deviation at chest X-Ray (yes; no) as predictive parameter for difficult intubation
through study completion, an average of 2 year
History of difficult tracheal intubation (yes; no) as predictive parameter for difficult intubation
Time Frame: through study completion, an average of 2 year
preoperative History of difficult tracheal intubation (yes; no) as predictive parameter for difficult intubation
through study completion, an average of 2 year
Total body weight (kg) as predictive parameter for difficult intubation
Time Frame: through study completion, an average of 2 year
preoperative Total body weight (kg) as predictive parameter for difficult intubation
through study completion, an average of 2 year
Neck motility (<80°;80-90°;>90°) as predictive parameter for difficult intubation
Time Frame: through study completion, an average of 2 year
preoperative Neck motility (<80°;80-90°;>90°) as predictive parameter for difficult intubation
through study completion, an average of 2 year
Thyromental distance (cm) as predictive parameter for difficult intubation
Time Frame: through study completion, an average of 2 year
preoperative Thyromental distance (cm) as predictive parameter for difficult intubation
through study completion, an average of 2 year
Mediastinal goiter (yes; no) as predictive parameter for difficult intubation
Time Frame: through study completion, an average of 2 year
preoperative Mediastinal goiter (yes; no) as predictive parameter for difficult intubation
through study completion, an average of 2 year
Prognathism (yes; no) as predictive parameter for difficult intubation
Time Frame: through study completion, an average of 2 year
preoperative Prognathism (yes; no) as predictive parameter for difficult intubation
through study completion, an average of 2 year
Mallampati test (1;2;3;4) as predictive parameter for difficult intubation
Time Frame: through study completion, an average of 2 year
preoperative Mallampati test (1;2;3;4) as predictive parameter for difficult intubation
through study completion, an average of 2 year
Inter-incisor gap (cm) as predictive parameter for difficult intubation
Time Frame: through study completion, an average of 2 year
preoperative Inter-incisor gap (cm) as predictive parameter for difficult intubation
through study completion, an average of 2 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2017

Primary Completion (Actual)

September 17, 2018

Study Completion (Actual)

September 17, 2018

Study Registration Dates

First Submitted

February 19, 2018

First Submitted That Met QC Criteria

July 3, 2018

First Posted (Actual)

July 6, 2018

Study Record Updates

Last Update Posted (Actual)

September 20, 2018

Last Update Submitted That Met QC Criteria

September 19, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 4133/AO/17

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

Probably all IPD will be shared at the end of the study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intubation;Difficult

Clinical Trials on Thyroid surgery

3
Subscribe